187 related articles for article (PubMed ID: 3546461)
1. Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antimyosin Fab.
Addonizio LJ; Michler RE; Marboe C; Esser PE; Johnson LL; Seldin DW; Gersony WM; Alderson PO; Rose EA; Cannon PJ
J Am Coll Cardiol; 1987 Mar; 9(3):555-64. PubMed ID: 3546461
[TBL] [Abstract][Full Text] [Related]
2. The role of indium-111 antimyosin (Fab) imaging as a noninvasive surveillance method of human heart transplant rejection.
De Nardo D; Scibilia G; Macchiarelli AG; Cassisi A; Tonelli E; Papalia U; Gallo P; Antolini M; Pitucco G; Reale A
J Heart Transplant; 1989; 8(5):407-12. PubMed ID: 2795283
[TBL] [Abstract][Full Text] [Related]
3. Measurement of infarct size and percentage myocardium infarcted in a dog preparation with single photon-emission computed tomography, thallium-201, and indium 111-monoclonal antimyosin Fab.
Johnson LL; Lerrick KS; Coromilas J; Seldin DW; Esser PD; Zimmerman JM; Keller AM; Alderson PO; Bigger JT; Cannon PJ
Circulation; 1987 Jul; 76(1):181-90. PubMed ID: 2439232
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive detection of human cardiac transplant rejection with indium-111 antimyosin (Fab) imaging.
Frist W; Yasuda T; Segall G; Khaw BA; Strauss HW; Gold H; Stinson E; Oyer P; Baldwin J; Billingham M
Circulation; 1987 Nov; 76(5 Pt 2):V81-5. PubMed ID: 3311460
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal Fab antimyosin in cardiac imaging.
Johnson LL
Clin Cardiol; 1992 Mar; 15(3):145-53. PubMed ID: 1551261
[TBL] [Abstract][Full Text] [Related]
6. Scintigraphy and immunohistology of antimyosin-Fab during graft rejection.
Breuer M; Schütz A; Engelhardt M; Hammer C; Kemkes BM
Angiology; 1999 Jul; 50(7):563-71. PubMed ID: 10431996
[TBL] [Abstract][Full Text] [Related]
7. Burden of myocardial damage in cardiac allograft rejection: scintigraphic evidence of myocardial injury and histologic evidence of myocyte necrosis and apoptosis.
Puig M; Ballester M; Matías-Guiu X; Bordes R; Carrió I; Kolodgie FD; Pons C; García A; Aymat MR; Marrugat J; Brossa V; Campreciós M; Padró JM; Caralps JM; Virmani R; Prat J; Narula J
J Nucl Cardiol; 2000; 7(2):132-9. PubMed ID: 10796002
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of biopsy classification for rejection: relation to detection of myocardial damage by monoclonal antimyosin antibody imaging.
Ballester M; Bordes R; Tazelaar HD; Carrió I; Marrugat J; Narula J; Billingham ME
J Am Coll Cardiol; 1998 May; 31(6):1357-61. PubMed ID: 9581733
[TBL] [Abstract][Full Text] [Related]
9. Antimyosin imaging in cardiac transplant rejection.
Johnson LL; Cannon PJ
Circulation; 1991 Sep; 84(3 Suppl):I273-9. PubMed ID: 1884496
[TBL] [Abstract][Full Text] [Related]
10. Imaging of cardiac transplantation rejection in primates using two new antimyosin agents.
Vaccarino RA; Sanchez JE; Johnson LL; Wang TS; Seldin DW; Marboe C; Egbe P; Bhatia K; Rose EA; Khaw BA
J Nucl Med; 1992 Nov; 33(11):1994-9. PubMed ID: 1432161
[TBL] [Abstract][Full Text] [Related]
11. Early detection of rejection and assessment of cyclosporine therapy by 111In antimyosin imaging in mouse heart allografts.
Isobe M; Haber E; Khaw BA
Circulation; 1991 Sep; 84(3):1246-55. PubMed ID: 1884451
[TBL] [Abstract][Full Text] [Related]
12. Effect of cyclosporine on the uptake of monoclonal antibody to cardiac myosin.
Allen MD; Shoji Y; Fujimura Y; Eary JF; Reichenbach DD; Thomas R; Gordon D
J Heart Lung Transplant; 1991; 10(5 Pt 1):775-81. PubMed ID: 1958686
[TBL] [Abstract][Full Text] [Related]
13. Antimyosin monoclonal antibodies for early detection of cardiac allograft rejection.
Schuetz A; Fritsch S; Kemkes BM; Kugler C; Angermann C; Spes C; Anthuber M; Weiler A; Wenke K; Gokel JM
J Heart Transplant; 1990; 9(6):654-61. PubMed ID: 2277304
[TBL] [Abstract][Full Text] [Related]
14. Identification of cardiac rejection in heterotopic heart transplantation using 111In-antimyosin.
Nishimura T; Sada M; Sasaki H; Yutani C; Hayashi M; Amemiya H; Fujita T; Akutsu T; Manabe H
Eur J Nucl Med; 1987; 13(7):343-7. PubMed ID: 3322830
[TBL] [Abstract][Full Text] [Related]
15. Assessment of severity of cardiac rejection in heterotopic heart transplantation using indium-111 antimyosin and magnetic resonance imaging.
Nishimura T; Sada M; Sasaki H; Yutani C; Fujita T; Amemiya H; Kozuka T; Akutsu T; Manabe H
Cardiovasc Res; 1988 Feb; 22(2):108-12. PubMed ID: 3048691
[TBL] [Abstract][Full Text] [Related]
16. [Experiences with the application of monoclonal Indium-111 antimyosin scintigraphy in the diagnosis of rejection episodes following orthotopic heart transplantation].
Hartmann A; Baum RP; Klepzig H; Huth A; Mondorf U; Herrmann G; Cieslinski G; Olbrich HG; Hör G; Krause E
Z Kardiol; 1991 Jul; 80(7):454-8. PubMed ID: 1926991
[TBL] [Abstract][Full Text] [Related]
17. Indium-111-monoclonal antimyosin antibody studies after the first year of heart transplantation. Identification of risk groups for developing rejection during long-term follow-up and clinical implications.
Ballester M; Obrador D; Carrió I; Augé JM; Moya C; Pons-Lladó G; Caralps-Riera JM
Circulation; 1990 Dec; 82(6):2100-7. PubMed ID: 2242534
[TBL] [Abstract][Full Text] [Related]
18. Kinetics and dynamics of acute rejection after heterotopic heart transplantation.
Schüetz A; Kemkes BM; Breuer M; Brandl U; Engelhardt M; Kugler C; Manz C; Hatz R; Gokel JM; Hammer C
J Heart Lung Transplant; 1992; 11(2 Pt 1):289-99; discussion 299-300. PubMed ID: 1576135
[TBL] [Abstract][Full Text] [Related]
19. Is In-111 antimyosin antibody a useful diagnostic marker for evaluation of early cardiac allograft rejection?
Ueda K; Takeda K; LaFrance ND; Solez K; Baumgartner WA; Reitz BA; Herskowitz A
Transplant Proc; 1988 Feb; 20(1 Suppl 1):778-81. PubMed ID: 2831646
[No Abstract] [Full Text] [Related]
20. Detection of cardiac allograft rejection and myocyte necrosis by monoclonal antibody to cardiac myosin.
Allen MD; Tsuboi H; Togo T; Eary JF; Gordon D; Thomas R; Reichenbach DD
Transplantation; 1989 Dec; 48(6):923-8. PubMed ID: 2595780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
